Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

4D Molecular Therapeutics

Biotech & Life Sciences · Emeryville, United States · Founded 2013 · IPO 2020 Colt

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$79M
Market cap · Apr/2026
Revenue
$85M
Latest reported FY

Investors

21 investors on 4D Molecular Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 1 investor entered at this stage
Cystic Fibrosis Foundation
Series B+ 20 investors entered at this stage
BVF Partners
Casdin Capital
Mirae Asset Capital
Viking Global Investors
Longevity Vision Fund
Cure Duchenne
Ridgeback Capital
Octagon investments
Pappas Capital
QUAD Investment Management
Perceptive Advisors
ArrowMark Partners
Pfizer Ventures
Amzak Capital Management
Berkeley Catalyst Fund
Chiesi Ventures
Pfizer
Janus Henderson Investors
University of California
Berkeley

Global footprint

Where 4D Molecular Therapeutics has talent and traffic

Web traffic by country
15K monthly visits
across markets
🇺🇸 United States61.3%
🇮🇳 India18.7%
🇬🇧 United Kingdom10.7%
🏳️ Korea6%
🏳️ Republic of1.3%
Top 5 markets shown

See 4D Molecular Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo